-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Initiates Coverage On Abivax with Outperform Rating, Announces Price Target of $176

Benzinga·11/06/2025 13:22:54
Listen to the news
Wolfe Research analyst Steve Fleishman initiates coverage on Abivax (NASDAQ:ABVX) with a Outperform rating and announces Price Target of $176.